Literature DB >> 20139278

Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.

Lichun Dong1, Penny Li, Tjitske Oenema, Christopher L McClurkan, David M Koelle.   

Abstract

Recombination of germline TCR alpha and beta genes generates polypeptide receptors for MHC peptide. Ag exposure during long-term herpes simplex infections may shape the T cell repertoire over time. We investigated the CD8 T cell response to HSV-2 in chronically infected individuals by sequencing the hypervariable regions encoding TCR alpha and beta polypeptides from T cell clones recognizing virion protein 22 aa 49-57, an immunodominant epitope. The most commonly detected TCRBV gene segment, found in four of five subjects and in 12 of 50 independently derived T cell clones, was TCRBV12-4. Nineteen to seventy-two percent of tetramer-binding cells in PBMCs were stained ex vivo with a TCRBV12 mAb. Three alpha-chain and three beta-chain public TCR sequences were shared between individuals. Public heterodimers were also detected. Promiscuous pairing of a specific TCRVA1-1 sequence with several different TCRB polypeptides was observed, implying a dominant structural role for the TCRA chain for these clonotypes. Functional avidity for cytotoxicity and IFN-gamma release was relatively invariant, except for one subject with both high avidity and unique TCR sequences and lower HSV-2 shedding. These data indicate that the CD8 response to a dominant alpha-herpesvirus epitope converges on preferred TCR sequences with relatively constant functional avidity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139278      PMCID: PMC2863070          DOI: 10.4049/jimmunol.0903622

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.

Authors:  Emanuela M Iancu; Patricia Corthesy; Petra Baumgaertner; Estelle Devevre; Verena Voelter; Pedro Romero; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

2.  CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.

Authors:  D M Koelle; H B Chen; M A Gavin; A Wald; W W Kwok; L Corey
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?

Authors:  Christine M Posavad; Anna Wald; Nancy Hosken; Meei Li Huang; David M Koelle; Rhoda L Ashley; Lawrence Corey
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

4.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice.

Authors:  Lawrence T Feldman; Aaron R Ellison; Cynthia C Voytek; Li Yang; Philip Krause; Todd P Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

6.  Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; B N Carriere; R L Hendricks
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.

Authors:  David M Koelle; Zhi Liu; Christopher M McClurkan; Max S Topp; Stanley R Riddell; Eric G Pamer; Andrew S Johnson; Anna Wald; Lawrence Corey
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.

Authors:  Stéphanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; François Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; Bérangère Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

9.  CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; X Chen; D J Fink; R L Hendricks
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more
  20 in total

1.  Clonal expansions of CD8⁺ T cells in latently HSV-1-infected human trigeminal ganglia.

Authors:  Kathrin Held; Ingrid Eiglmeier; Susanne Himmelein; Inga Sinicina; Thomas Brandt; Diethilde Theil; Klaus Dornmair; Tobias Derfuss
Journal:  J Neurovirol       Date:  2011-12-14       Impact factor: 2.643

Review 2.  Determinants of public T cell responses.

Authors:  Hanjie Li; Congting Ye; Guoli Ji; Jiahuai Han
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

Review 3.  Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.

Authors:  K J Laing; L Dong; J Sidney; A Sette; D M Koelle
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

4.  Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.

Authors:  Michael T Hensel; Tao Peng; Anqi Cheng; Stephen C De Rosa; Anna Wald; Kerry J Laing; Lichen Jing; Lichun Dong; Amalia S Magaret; David M Koelle
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 5.  Donor Unrestricted T Cells: A Shared Human T Cell Response.

Authors:  Ildiko Van Rhijn; D Branch Moody
Journal:  J Immunol       Date:  2015-09-01       Impact factor: 5.422

6.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 7.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

8.  Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.

Authors:  Anthony J St Leger; Bjoern Peters; John Sidney; Alessandro Sette; Robert L Hendricks
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

9.  Anti-tumour immunity induces aberrant peptide presentation in melanoma.

Authors:  Osnat Bartok; Abhijeet Pataskar; Remco Nagel; Maarja Laos; Eden Goldfarb; Deborah Hayoun; Ronen Levy; Pierre-Rene Körner; Inger Z M Kreuger; Julien Champagne; Esther A Zaal; Onno B Bleijerveld; Xinyao Huang; Juliana Kenski; Jennifer Wargo; Alexander Brandis; Yishai Levin; Orel Mizrahi; Michal Alon; Sacha Lebon; Weiwen Yang; Morten M Nielsen; Noam Stern-Ginossar; Maarten Altelaar; Celia R Berkers; Tamar Geiger; Daniel S Peeper; Johanna Olweus; Yardena Samuels; Reuven Agami
Journal:  Nature       Date:  2020-12-16       Impact factor: 49.962

Review 10.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.